Clinical trial
Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host Disease
NCT01977781 is registered in ClinicalTrials.gov with Massachusetts Eye and Ear Infirmary as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host Disease
- Lead sponsor
- Massachusetts Eye and Ear Infirmary
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 31, 2013
- Completion date
- September 30, 2014
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ocular gvhd